Effect of nepafenac eye drops on pain associated with pterygium surgery.

Abstract

OBJECTIVE:

To assess the effects of nepafenac ophthalmic suspension 0.1% for control of pain in patients undergoing pterygium surgery.

METHODS:

This randomized, double-masked placebo-controlled study included 62 adults undergoing pterygium surgery. Patients were randomly assigned to receive nepafenac ophthalmic suspension 0.1% or balanced salt solution placebo. They were asked to assess the level of pain using an 11-point numeric rating scale at 6, 12, 24, 48, and 72 hr after surgery. Patients also were evaluated daily for the progression of corneal epithelial healing until complete closure was observed.

RESULTS:

Except at 72 hr after surgery, the patients reported significantly less pain in eyes receiving nepafenac than in eyes receiving placebo. There was no statistical difference between the two groups in corneal epithelial healing.

CONCLUSIONS:

Treatment with nepafenac ophthalmic suspension 0.1% significantly reduced postoperative pain compared with placebo after pterygium surgery.

• Authors: Muammer Ozcimen, Yasar Sakarya, Sertan Goktas, Rabia Sakarya, Halil I Yener, Abdulkadir Bukus, Lutfi S Demir
• Journal: Eye & contact lens (Eye Contact Lens) Vol. 41 Issue 3 Pg. 187-9 (May 2015) ISSN: 1542-233X [Electronic] United States
• PMID: 25603438 (Publication Type: Journal Article, Randomized Controlled Trial)

Chemical References

• Anti-Inflammatory Agents, Non-Steroidal
• Benzeneacetamides
• Ophthalmic Solutions
• Phenylacetates
• nepafenac

Topics

• Adult
• Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
• Benzeneacetamides (administration & dosage)
• Double-Blind Method
• Female
• Humans
• Male
• Middle Aged
• Ophthalmic Solutions (administration & dosage)
• Pain, Postoperative (drug therapy)
• Phenylacetates (administration & dosage)
• Pterygium (surgery)